🏛️ Verified NIH Protocol • Sourced via U.S. National Library of Medicine (Last Synced: 2026-08-28)

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

🟢 Recruiting Phase 3 💊 Investigational Drug / Biologic Sponsor: Janssen Research & Development, LLC

🩺 Protocol Summary

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.

Primary Research Facility: Arkansas Urology (Little Rock, Arkansas)

📋 Basic Study Criteria & Logistics Checklist

0 of 3 Checked

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Non-Muscle Invasive Bladder Neoplasms?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged 18 Years or older?

🔍 Protocol Specified Minimum Age: 18 Years

Able to attend required in-person clinic visits and study procedures at one of the participating study centers?

🔍 Logistical Requirement: 193 Registered Participating Sites

📍 Primary Site Map

Site: Arkansas Urology — Little Rock, Arkansas

📍 All Participating Trial Locations (193 Sites)

Multi-Center Trial

This protocol is enrolling participants across multiple clinical centers:

1. Arkansas Urology — Little Rock, Arkansas

2. Genesis Research LLC — Los Alamitos, California

3. USC Norris Comprehensive Cancer Center — Los Angeles, California

4. University of California Irvine Medical Center — Orange, California

5. Om Research LLC — San Diego, California

6. Genesis Research LLC 1 — Sherman Oaks, California

7. University of Colorado Cancer Center Anschultz Cancer Pavilion — Aurora, Colorado

8. Colorado Clinical Research — Lakewood, Colorado

9. Moffitt Cancer Center — Tampa, Florida

10. Northwestern University — Chicago, Illinois

11. First Urology — Jeffersonville, Indiana

12. Wichita Urology Group — Wichita, Kansas

13. Ochsner Health System — New Orleans, Louisiana

14. Chesapeake Urology Research Associates — Hanover, Maryland

15. Brigham And Women's Hospital — Boston, Massachusetts

16. Karmanos Cancer Institute — Detroit, Michigan

17. Comprehensive Urology — Royal Oak, Michigan

18. Mercy Research — St Louis, Missouri

19. Specialty Clinical Research of St Louis — St Louis, Missouri

20. The Urology Center, PC — Omaha, Nebraska

21. Cancer Institute Of New Jersey — New Brunswick, New Jersey

22. Integrated Medical Professionals — New York, New York

23. Memorial Sloan Kettering Cancer Center — New York, New York

24. Associated Medical Professionals of Ny — Syracuse, New York

25. SUNY Upstate Med Univ — Syracuse, New York

📄 Print Doctor Discussion Sheet

Preview and print a 1-page summary with 5 tailored questions for your physician.

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.

🏛️ Official Government Provenance

NIH ClinicalTrials.gov Protocol Record

NCT Identifier: NCT06319820 • Last Synced: 2026-08-28

View on ClinicalTrials.gov ↗